Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMMP similar filings
- 5 Oct 22 Immutep Receives FDA Fast Track Designation for LAG-3 Therapeutic
- 23 Sep 22 Immutep Receives A$2.7 million R&D Tax Incentive from French Government
- 14 Sep 22 Immutep Clinical Development Update for its First-in-Class
- 13 Sep 22 Immutep Appoints LAG-3 Pioneer, Frédéric Triebel to Board
- 6 Sep 22 Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma
- 1 Sep 22 Preliminary final report
- 30 Aug 22 Current report (foreign)
Filing view
External links